Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.16 USD | +1.10% | +3.25% | +15.40% |
13/05 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
10/05 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Trading Ideas